Treating Addiction in Patients Transitioning to/from Incarceration
The Carlat Addiction Treatment Report, Volume 7, Number 5, August 2019
Topics: Addiction | Addiction Treatment | Buprenorphine | Clinical practice | Incarceration | Methadone | Naltrexone | Opioid epidemic | Opioid Use Disorder | Opioids | Overdose | Prison | Substance use disorders
Karen Cropsey, PsyD
Conatser Turner Endowed Professor of Psychiatry, University of Alabama at Birmingham
Dr. Cropsey has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Addiction treatment during incarceration is limited, and release from incarceration presents its own set of challenges. In this QA interview, Dr. Karen Cropsey discusses effective treatment options for patients with substance use disorders transitioning to or from incarceration.